No association to sudden infant death syndrome detected by targeted amplicon sequencing of 24 genes

Acta Paediatr. 2020 Dec;109(12):2636-2640. doi: 10.1111/apa.15295. Epub 2020 May 18.

Abstract

Aim: The aim was to identify genetic variants associated with sudden infant death syndrome (SIDS) that can cause disease or introduce vulnerability. Genes reported in a previous SIDS study to have altered messenger ribonucleic acid (mRNA) expression in SIDS were investigated.

Methods: Samples from 81 SIDS (56 male/28 female) with a median age of 4 months (range 0.75-9 months) were analysed using Illumina TruSeq custom amplicon for 24 selected genes. Samples were collected from autopsy at Oslo university hospital from children whom died suddenly and unexpectedly from 1988 to 2006. The controls were the germline variation database, Norgene (no description of cases available).

Results: After filtering for rare variants, there were a total of 38 variants in the 81 SIDS cases and 462 variants in the 789 controls. After the filtration and curation steps, we found 36 rare variants. The overall occurrence of rare variants for all the SIDS samples was lower than for the Norgene population.

Conclusion: There was no association between rare variants in the included genes and SIDS. Although not statistically significant, two of the SIDS cases had a rare variant in the MyD88 gene: rs746651350, rs200424253.

Keywords: genetic variation; immune system; infection; sequencing; sudden infant death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autopsy
  • Child
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Sudden Infant Death* / genetics